New transplant method offers hope for blood cancer patients
NCT ID NCT02623439
First seen Nov 10, 2025 · Last updated May 23, 2026 · Updated 23 times
Summary
This study tested a new way to do bone marrow transplants for people with blood cancers like leukemia. It used a partially matched donor and a drug called cyclophosphamide after the transplant to help prevent rejection. The goal was to see if patients could survive at least 180 days after the procedure. The study was stopped early, but it involved 10 adults aged 18 to 70.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UCSD Medical Center
La Jolla, California, 92093, United States
Conditions
Explore the condition pages connected to this study.